Table 3.
TNM staging
| Staging | 0 | I | II | IIIA | IIIB | IIIC | IVA | IVB |
|---|---|---|---|---|---|---|---|---|
| T | TIS | 1 | 2a-b | 3 | 4 | random | random | random |
| N | 0 | 0 | 0 | 0 | 0 | 1 | 2 | random |
| M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Note:
Tumor size (T);
TX: The primary tumor cannot be evaluated; T0: No evidence of primary tumor; Tis: Carcinoma in situ/Severe dysplasia; T1: Limited to bile ducts, reaching muscularis or fibrous tissue; T2a: Beyond the bile duct wall to the surrounding adipose tissue; T2b: Invasion of adjacent liver parenchyma; T3: Invasion of one branch of the portal vein or hepatic artery; T4: Invasion of the portal vein or its bilateral branches, or common hepatic artery, or bilateral secondary bile ducts; or tumor invasion of one secondary bile duct into the contralateral portal vein or hepatic artery.
Regional lymph nodes (N);
NX: Regional lymph node metastasis cannot be determined; N0: No regional lymph node metastasis; N1: 1 to 3 regional lymph nodes metastases; N2: Metastases in ≥4 regional lymph nodes;
Distant metastasis (M);
M0: No distant metastasis; M1: Distant metastases (including lymph node metastases beyond the hepatoduodenal ligament and the area behind the pancreatic head and duodenum).